2021 Food Advertising, Labeling, and Litigation Conference CLE
Why Attend Agenda CLE Continuing Legal Education
Why Attend Agenda CLE Continuing Legal Education
Top Food and Drug Cases, 2020, & Cases to Watch, 2021 FDLI’s Top Food and Drug Cases is the companion volume to the popular panel at our Annual Conference. Become A Member As a general matter, “looking back at 2020” is a singularly unpleasant prospect for the vast majority [...]
AMG Capital Management, LLC v. Federal Trade Commission T. DANIEL LOGAN & JAQUELINE J. CHAN* Why It Made the List On first glance, a case about the Federal Trade Commission’s (FTC’s) remedies against payday lending may not appear relevant to food and drug law and its practitioners. However, in effect, many agencies pull enforcement [...]
Why Attend Agenda CLE Continuing Legal Education
Why Attend Agenda CLE Tuesday, June 8 11:00–11:45 AM Bonus Session: A Primer on Regenerative Medicine Science and Recent Breakthroughs Heather C. Hatcher, Regulatory Scientist, Womble Bond Dickinson (US) LLP Collin Stabler, Senior Associate, Exponent, Inc. Moderated by Barbara A. Binzak Blumenfeld, Shareholder, Buchanan Ingersoll & Rooney PC [...]
Why Attend Agenda CLE Continuing Legal Education
Why Attend Agenda Agenda Subject to Change. All Times are Eastern Time. CLE Tuesday, May 18 Amy Comstock Rick, President & CEO, FDLI Stuart M. Pape, Senior Partner, Polsinelli PC and Co-Chair, 2021 FDLI Annual Conference Janet [...]
New, Emerging, and Continually Interesting Issues Discuss emerging issues in transitional biologics, FDA protein definition, labeling carve-outs and carve-ins, authorized biosimilars, advertising and promotion draft guidance, purple book reform, and FDA’s umbrella policy for Reference Product (RP) exclusivity. Scott M. Lassman , Principal, Lassman Law + Policy SCOTT M. [...]
Update Magazine | Spring 2021
Why Attend Agenda CLE Continuing Legal Education
Virtual Learning
Programs
Resources
Get Involved
Career
About
Fill out the form below to receive emails highlighting our upcoming programs, early registration savings, and engagement opportunities for the food and drug law community.